(1)
- Rise in investments on contract research manufacturing services (CRAMS) by drug-making companies boost lyophilized injectable drugs market
- Prevalence of metabolic disorders drives optimization of the process of lyophilisation of injectables, demand for new drug formulations for chronic disease management spurs demand in North America
ALBANY, N.Y., March 2, 2021 /PRNewswire/ Lyophilization is a crucial process for injectable for achieving a stable drug product and in ensuring an adequate biological activity. The process regulates numerous key drug product quality attributes such as the cake stability during storage and transportation. A majority of biopharmaceutical such as proteins, vaccines, antibodies, enzymes, biologics, peptides, and plasma need to undergo adequate lyophilisation before commercialization. The process is also being used for some diagnostic reagents, especially those used in IVD. Types of packaging used for lyophilized injectable drugs are single-use v